A clinical trial to study the effects of Bobath therapy with and without EMG Biofeedback therapy in stroke patients
- Conditions
- Health Condition 1: I699- Sequelae of unspecified cerebrovascular diseases
- Registration Number
- CTRI/2023/04/051999
- Lead Sponsor
- SANLAP KUND
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 52
1. Both male and female patients aged between 40 – 65 years.
2. Patients with first attack of stroke, diagnosed by a physician.
3. Duration of stroke 3 months to 3 years.
4. Patient has no cognitive impairment and has a MMSE Score = 24.
5. Grade of spasticity upto 2 in lower extremity on Modified Ashworth Scale.
6. Patient is in Brunnstorm lower limb recovery stage 3 and 4.
7. Patient should have passive 10° or greater ankle dorsiflexion.
8. Patient can sit independently on a plinth.
9. Patient should be ambulatory either independently or with some assistive aid.
1. Patient with any sensory deficit of the lower extremity.
2. Problems with vision, like – homonymous hemianopsia, hemi agnosia, visual agnosia etc.
3. Patients with hearing loss.
4. Patients with hemineglect.
5. Patients with sensory, conduction or global aphasia.
6. Musculoskeletal conditions like – fracture, contracture and deformity in lower extremity.
7. Diagnosed neurological diseases like – Parkinsonism, Dementia, Peripheral nerve injury in the lower extremity etc.
8. Diagnosed systemic diseases like – uncontrolled hypertension etc. and/or peripheral vascular disease in lower extremity like – Raynaud’s disease etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method